Cooperative Agreement FA86502526L18
Award Date
6/11/25
Completion Date
6/24/25
Dollars Obligated
$514K
Funding Federal Agency
Air Force
Awarding Federal Agency
Air Force Research Laboratory
Federal Grant Program
12.800
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
The University of Maryland, Baltimore (UMB) was awarded a $479,000 Cooperative Agreement by the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800). The award, titled "Measuring Dysautonomia for the Rapid Determination and Progression of TBI", began on March 14, 2025 and is scheduled for completion on March 14, 2028. Through this Cooperative Agreement, UMB will conduct research to advance scientific understanding in areas critical to national defense...
This $1,500,000 Cooperative Agreement award from the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) supports the development of a "Triage Clinical Decision Support for Prolonged Field Care Scenarios" at the University of Maryland, Baltimore (UMB). The project aims to advance medical decision support capabilities for military personnel in prolonged field care situations. UMB, a prominent public research university, will leverage its expertise in...
This Cooperative Agreement award from the Department of the Air Force's Defense Research Sciences Program (CFDA 12.800) provides $167,000.00 to the University of Maryland, Baltimore (UMB) to study the "Effects of Long-Range Aeromedical Evacuation on Military Relevant Complex Injuries". The performance period for this award is from July 26, 2023 to October 26, 2024. UMB, as the prime awardee, will leverage its expertise and facilities in medical and biomedical research to conduct this...
This federal Cooperative Agreement award from the Department of the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) provides $275,000.00 in funding to the University of Maryland, Baltimore (UMB) to conduct a "Study of the Delay of Oxygenation from the Lung to the Finger Using a Rapid and Automated Protocol." The award period is from July 10, 2024 to January 9, 2026. The Air Force Defense Research Sciences Program supports fundamental and applied scientific...
This Cooperative Agreement award from the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) provides $466,000.00 in funding to the University of Maryland, Baltimore (UMB) to support research targeting extracellular miRNAs sensing in trauma-induced acute lung injury. The award commenced on Apr 29, 2025 and is scheduled for completion on the same date. UMB, a prominent public research university, will leverage its expertise in biomedical research and clinical...
This Cooperative Agreement, awarded by the Air Force Research Laboratory (AFRL) under the Air Force Defense Research Sciences Program (CFDA 12.800), provides $202,407.00 to the University of Maryland, Baltimore (UMB) to develop an extended reality (XR) tool to assess procedural readiness in USAF medical forces. The performance period for this award is from May 29, 2024 to May 29, 2025. The goal of this project is to create innovative XR-based training solutions that can enhance the...
This Cooperative Agreement award from the U.S. Air Force under CFDA 12.800 - Air Force Defense Research Sciences Program provides $730,466.18 in funding to the University of Maryland, Baltimore (UMB) for the "AUSTERE ECMO VALIDATION" project. The award period runs from February 2, 2024 to February 2, 2026. The project is focused on conducting research and validation activities related to extracorporeal membrane oxygenation (ECMO) technology in austere environments. UMB, a major...
The University of Maryland, College Park was awarded a $280,000 Project Grant from the Department of the Air Force Materiel Command Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) to conduct research on multiscale characterization of collective astrocyte dynamics from August 1, 2021 through July 31, 2023. As part of the Air Force Defense Research Sciences Program, which aims to maintain Air Force technological superiority through basic and applied...
This $501,000 Cooperative Agreement award from the U.S. Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) is supporting research at the University of Maryland, Baltimore to investigate the use of deferoxamine as a resuscitative adjuvant to mitigate damage caused by combined traumatic brain injury. The project, which runs from March 2025 to March 2028, aims to advance scientific understanding and develop potential treatments in this critical area of national defense....
The University of Maryland, College Park was awarded a $750,000 Project Grant from the Air Force Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) to conduct research on "ENGINEERING THE MULTIMODAL AND MULTISCALE BIOPHYSICS OF NEURAL NETWORKS FOR NEUROMORPHIC COMPUTING AND QUANTUM SENSING". The award period is from Nov 1, 2024 to Apr 30, 2026. The research aims to advance scientific understanding and technological innovation in areas critical to...